125 related articles for article (PubMed ID: 6137754)
1. Extrapancreatic action of sulfonylureas: hypoglycemic effects are not dependent on altered insulin binding or inhibition of transglutaminase.
Nowak SM; McCaleb ML; Lockwood DH
Metabolism; 1983 Apr; 32(4):398-402. PubMed ID: 6137754
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea effects on target tissues for insulin.
McCaleb ML; Maloff BL; Nowak SM; Lockwood DH
Diabetes Care; 1984; 7 Suppl 1():42-6. PubMed ID: 6376028
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.
Maloff BL; Lockwood DH
J Clin Invest; 1981 Jul; 68(1):85-90. PubMed ID: 7019248
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transglutaminase by hypoglycaemic sulphonylureas in pancreatic islets and its possible relevance to insulin release.
Gomis R; Mathias PC; Lebrun P; Malaisse-Lagae F; Sener A; Malaisse WJ
Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):331-49. PubMed ID: 6151221
[TBL] [Abstract][Full Text] [Related]
5. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
6. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
De Vries CP; van der Veen EA
Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
[TBL] [Abstract][Full Text] [Related]
7. Extrapancreatic effects of sulfonylureas. Potentiation of insulin action through post-binding mechanisms.
Lockwood DH; Maloff BL; Nowak SM; McCaleb ML
Am J Med; 1983 Jan; 74(1A):102-8. PubMed ID: 6401922
[TBL] [Abstract][Full Text] [Related]
8. Influence of sulfonylureas on the secretion, disposal and effect of insulin.
Almér LO; Johansson E; Melander A; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169
[TBL] [Abstract][Full Text] [Related]
9. Cellular loci of sulfonylurea actions.
Lebovitz HE
Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats.
Salhanick AI; Konowitz P; Amatruda JM
Diabetes; 1983 Mar; 32(3):206-12. PubMed ID: 6337899
[TBL] [Abstract][Full Text] [Related]
11. Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary culture.
Rinninger F; Kirsch D; Häring HU; Kemmler W
Diabetologia; 1984 Jun; 26(6):462-5. PubMed ID: 6381193
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.
Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):469-87. PubMed ID: 8911985
[TBL] [Abstract][Full Text] [Related]
13. Hepatic sensitivity to insulin: effects of sulfonylurea drugs.
Del Prato S; Vigili de Kreutzenberg S; Riccio A; Tiengo A
Am J Med; 1991 Jun; 90(6A):29S-36S. PubMed ID: 1872301
[TBL] [Abstract][Full Text] [Related]
14. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
[TBL] [Abstract][Full Text] [Related]
15. The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity.
Gomis R; Casanovas A; Casamitjana R; Sarto A; Arroyo J; Coves MJ; Rivera F; Vilardell E
Diabetes Res Clin Pract; 1988 May; 5(1):31-6. PubMed ID: 2900125
[TBL] [Abstract][Full Text] [Related]
16. Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.
Putnam WS; Andersen DK; Jones RS; Lebovitz HE
J Clin Invest; 1981 Apr; 67(4):1016-23. PubMed ID: 7009650
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
[TBL] [Abstract][Full Text] [Related]
18. Insulin binding on MOLT 4 cells: effect of a sulfonylurea.
Cordera R; Chimini G; Bagnasco M; Gherzi R
Horm Res; 1984; 20(4):246-51. PubMed ID: 6392057
[TBL] [Abstract][Full Text] [Related]
19. Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids.
Brown GR; Foubister AJ
J Med Chem; 1984 Jan; 27(1):79-81. PubMed ID: 6361256
[TBL] [Abstract][Full Text] [Related]
20. Effect of glipizide on muscle metabolism in vitro.
Bloch K; Daturi S; Tommasini R
Acta Endocrinol Suppl (Copenh); 1980; 239():23-5. PubMed ID: 7001841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
